By repurposing the vector used in the long-proven smallpox vaccine, Michinori Kohara hopes to offer more enduring COVID-19 protection against variants that have yet to develop.
( read original story …)
The Japan News
By repurposing the vector used in the long-proven smallpox vaccine, Michinori Kohara hopes to offer more enduring COVID-19 protection against variants that have yet to develop.
( read original story …)